Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolismJean‐Charles Lambert, Frédéric Checler, Ronald C. Petersen et al.|Acta Neuropathologica|2016Cited by 78
Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent mannerFanny Eysert, Julien Chapuis, Audrey Coulon et al.|Molecular Psychiatry|2020Cited by 59
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Jean‐Charles Lambert, Geoffroy Laumet et al.|EBioMedicine|2016Cited by 52
Influence of Region‐Specific Alterations of Neuropeptidase Content on the Catabolic Fates of Neuropeptides in Alzheimer's DiseaseCarole Ichai, Frédéric Checler, Nathalie Chevallier et al.|Journal of Neurochemistry|1994Cited by 51
M<sub>1</sub>and M<sub>3</sub>Muscarinic Receptors Control Physiological Processing of Cellular Prion by Modulating ADAM17 Phosphorylation and ActivityMoustapha Cissé, Frédéric Checler|Journal of Neuroscience|2007Cited by 49